Perspectives
Rare voices, real change: Community-based advocacy efforts driving big impact
Patient Voice sat down with Beth Vanstone and Alice Williams, rare disease advocates and Ontario Rare Action Group co-founders, to discuss diagnosis, treatment and care gaps — and how grassroots advocacy can drive meaningful change.
Industry Voice
In conversation with Gilead Canada’s Christophe Griolet
Industry Voice sat down with Christophe Griolet, General Manager of Gilead Sciences Canada, to discuss how he applies global learnings in a local context, his commitment to health equity, and the incredible promise of personalized medicine.
